{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-086061","form_type":"8-K","ticker":"SEM","cik":"0001320414","company_name":"SELECT MEDICAL HOLDINGS CORP","filed_at":"2022-08-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.357995+00:00","generated_at":"2026-06-24T03:48:15.578370+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Select Medical awards 900,000 restricted shares to top executives under 2020 Plan","bullets":["Total of 900,000 restricted shares awarded to five named executive officers.","Shares vest equally over three years from grant date August 1, 2022.","CEO David Chernow and Vice Chairman Robert Ortenzio each received 250,000 shares.","President Rocco Ortenzio and CFO Martin Jackson each received 150,000 shares.","EVP, General Counsel Michael Tarvin received 100,000 shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-086061","json":"https://secwatch.observer/filing/0001104659-22-086061.json","markdown":"https://secwatch.observer/filing/0001104659-22-086061.md","text":"https://secwatch.observer/filing/0001104659-22-086061.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1320414/000110465922086061/0001104659-22-086061-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1320414/000110465922086061/tm2222622d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T03:48:15.578370+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}